Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lifetech LAmbre™ Left Atrial Appendage (LAA) Closure System Post-Market Clinical Follow-up: MULTI-CENTER, SINGLE-ARM, PROSPECTIVE, POST-MARKET STUDY

NCT03666780 is registered in ClinicalTrials.gov with Lifetech Scientific (Shenzhen) Co., Ltd. as lead sponsor.

NCT NCT03666780
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03666780 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lifetech LAmbre™ Left Atrial Appendage (LAA) Closure System Post-Market Clinical Follow-up: MULTI-CENTER, SINGLE-ARM, PROSPECTIVE, POST-MARKET STUDY
Lead sponsor
Lifetech Scientific (Shenzhen) Co., Ltd.
Phase
Observational
Overall status
Completed
Start date
November 16, 2018
Completion date
September 30, 2024
Enrollment
500 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation